New Animal Study Of Rexahn's Serdaxin™ Shows Drug's Promise To Treat Anxiety And Depression With Minimal Side Effects
Links shared publicly online about this topic.
- 1,963total visits
New Animal Study Of Rexahn's Serdaxin™ Shows Drug's Promise To Treat Anxiety And Depression With Minimal Side Effects
View full resource at medicalnewstoday.com
Tags: Alzheimer's Disease, Parkinson's Disease, Anxiety Disorder, Anxiety, Depression, Drug, Nature
Most Recently Shared on June 18, 2009 at 12:50 am By:
Novel neuroprotective agent shows potential for treatment of anxiety, depression, Parkinsons and Alzheimers. http://bit.ly/ZIRiZ
Also Shared By:
New Animal Study Featured In The Journal Of Cellular Biochemistry Supports Rexahn's Archexin™ As Potent Inhibitor Of Human Cancer Cell Growth
medicalnewstoday.com — “Rexahn pharmaceuticals, inc. (nyse amex: rnn), a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (cns) therapeutics, announced the” View full resource at medicalnewstoday.com
Most Recently Shared on October 25, 2009 at 10:03 am By:
New Animal Study Featured In The Journal Of Cellular Biochemistry Supports Rexahn's Archexin™ As Potent .. http://bit.ly/OZY98
Archexin has potential to target and treat multiple life-threatening cancers, finds new study
news-medical.net — “Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin", as having the potential to target and treat multiple life-threatening cancers.” View full resource at news-medical.net
Most Recently Shared on October 23, 2009 at 4:37 pm By:
News-Medical.Net Health News and Oncology
Oncology News: Archexin has potential to target and treat multiple life-threatening cancers, find.. http://bit.ly/xF14U
New Animal Study Of Rexahn's Serdaxinâ„¢ Shows Drug's Promise To Treat Anxiety And Depression With Minimal Side Effects | Psydir News
news.psydir.com — “Rexahn pharmaceuticals, inc. (nyse amex: rnn), announced the results of a wide-ranging animal study offering more evidence that serdaxinâ„¢ may be an effective therapeutic for the treatment of anxiety disorders in humans. serdaxin is rexahn's leading anxiety and depression drug candidate, and is currently in phase ii clinical trials.” View full resource at news.psydir.com
Most Recently Shared on June 17, 2009 at 5:07 pm By:
New Animal Study Of Rexahn's Serdaxinâ„¢ Shows Drug's Promise To Treat Anxiety And Depression With Minimal Side Ef.. http://bit.ly/8Gxwx
Advertisement
psychiatryrounds
@psychiatry_md
New Animal Study Of Rexahn's Serdaxin™ Shows Drug's Promise To Treat Anxiety And Depression With Minimal .. http://tinyurl.com/mo9pm4
1 year ago...